PL-8177

PL-8177 · Palatin Technologies, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PL-8177, covering 2025-03-05 to 2025-03-05. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC) [Phase 2]